We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current EVFM market cap is 151.3k. The company's latest EPS is USD 4.6593 and P/E is 0.10.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 446k | 8.24M | 16.84M | 18.22M |
| Operating Income | -52.74M | -103.62M | -166.8M | -84.12M | -17.85M |
| Net Income | -80.03M | -142.31M | -206.24M | -78.01M | 50M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 28.3M | 109.97M | 42.51M | 25.16M | 10.55M |
| Total Liabilities | 12.66M | 108.62M | 142.09M | 96.96M | 72.47M |
| Total Equity | 15.64M | 1.35M | -104.32M | -71.8M | -66.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -55.1M | -104.83M | -146.67M | -70.41M | -8.97M |
| Investing | -8.12M | 6.23M | -2.69M | -341k | -4k |
| Financing | 78.08M | 154.23M | 90.69M | 61.94M | 4.78M |
| Market Cap | 151.3k |
| Price to Earnings Ratio | 0.10 |
| Price to Sales Ratio | 0.28 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -0.08 |
| Dividend Yield | - |
| Shares Outstanding | 10.73M |
| Average Volume (1 week) | 627.12k |
| Average Volume (1 Month) | 889.63k |
| 52 Week Change | -99.55% |
| 52 Week High | 4.3625 |
| 52 Week Low | 0.0122 |
| Spread (Intraday) | 0.02 (99.41%) |
| Company Name | Evofem Biosciences Inc (QB) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.evofem.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
